A research paper by scientists at Tianjin Medical University employed the conditional/conjunctional false discovery rate (cond/conjFDR) approach to investigate the genetic overlap between schizophrenia and white matter microstructure..

A research paper by scientists at Wenzhou Medical University developes a mannose-modified pH/glutathione (GSH) dual-responsive nano-delivery system (MPP@IKE-aPD-1/diABZI) that synergistically activates ferroptosis and immune responses to achieve efficient antitumor therapy.

The University of East London (UEL) is leading a major new neuroscience research project in partnership with The Queen’s Reading Room, founded by Her Majesty Queen Camilla, and The Bentley Foundation. Headed by Professor Sam Wass,  Director of the Institute for the Science of Early Years and Youth (ISEY) at UEL, the laboratory-controlled study will examine the psychological and physiological impact of shared reading and book clubs, exploring how reading together can reduce stress, strengthen social bonds and improve mental wellbeing.

Building on The Queen’s Reading Room’s groundbreaking 2024 study which found that just five minutes of reading can reduce stress by nearly 20% and lower loneliness by up to 70%, the research will apply rigorous neuroscientific methods to understand the wider health and social benefits of communal reading.

CAMBRIDGE, Mass., January 23, 2026 --- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson’s Disease. 

Secondary lymphedema, a chronic condition caused by lymph node removal during cancer surgery, leads to swelling, pain, and reduced mobility with limited treatment options. In a recent study, researchers from Japan developed a centrifugal cell stacking technique to create artificial lymphatic tissues that can restore lymphatic flow. When transplanted into mice, CeLyTs form functional lymph node-like structures that reduce swelling and promote lymph flow, offering a promising therapeutic strategy for lymphedema.